Sai Life Sciences Sustainability Report 2022

14 ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................... Two global sites delivering integrated value Transfer to India reduces costs and cycle-time • Client & project specific exploratory biology • Target validation, novel assay development, etc. • Proximity to clients facilitaties collaboration & communication • Rapid reagent procurement enables nimble exploratory activities • Additional capabilities for high throughput in vitro assays • In vivo capabilities for PK/PD and efficacy • Co-localized with Synthetic Chemistry, ADME, PK, and Toxicology • Lower cost services Boston Hyderabad .

RkJQdWJsaXNoZXIy MTIwMDc4NQ==